ARCHIVES

Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP

This article is from The Cancer Letter archive.

Vol. 20 No. 25 | June 24, 1994

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

WHT Participants Get “Phase Out” Help

March 11, 1988

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

March 28, 1986

DCT Counselors Ponder Coordination, New Opportunities

December 12, 1975

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002